← All Vincerx Pharma, INC filings

Vincerx Pharma, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
VINC
Vincerx Pharma, INC
10-K: Vincerx Pharma Explores Strategic Alternatives Amidst Ongoing Losses in 2024
Vincerx Pharma reports its 2024 10-K filing, highlighting strategic shifts, ongoing losses, and a potential business combination with QumulusAI.
OTC.Pink
VINC
Vincerx Pharma, INC
10-K: Vincerx Pharma 2023 10-K Filing: Pipeline Progress and Financial Outlook
Vincerx Pharma's 2023 10-K filing details the company's clinical-stage pipeline, financial position, and strategic focus on its VersAptx platform.